The settlement’s existence after a 2017 accusation had been documented before the defense secretary nominee’s confirmation hearing this month, but the amount had not been known publicly.

Big business has an inside track in the second Trump presidency, and people with a stake in those businesses have reason to ...

Top advisers to Robert F. Kennedy Jr. are battling over how aggressively to target vaccines during his first days as the ...

Ascentage Pharma Group (AAPG) (AAPGV) (ASPHF), which is backed by Takeda (TAK), has priced a $126M U.S. initial public offering. Read more here.

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

The Host Julie Rovner KFF Health News @jrovner Read Julie's stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A ...

A recent health news roundup explores legal, financial, and strategic developments. Highlights include Robert F. Kennedy ...

Trump then went on to criticize the nation’s electric grid, calling it old while noting that he would allow the tech companies to rely on any fuel that they want to run the plants. And if the energy ...

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

Robert F. Kennedy Jr. is distancing himself from his anti-vaccine work as he seeks to become the leader of the nation’s top health agency under President Donald Trump, according to reports.

Donald Trump has outright admitted to profiling immigrants. Speaking with Fox News’s Sean Hannity Wednesday night in his ...

Robert F. Kennedy Jr. is backing away from his anti-vaccine work as he vies for leadership of the Health and Human Services ...